[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"nail-damage\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:nail-damage":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100595212","phase-3-study-to-assess-efficacy-safety-and-tolerability-of-a-nail-patch-in-patients-with-nail-fragility-mychosis-psoriasis-100595212",false,"NCT07029516","Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis","A Randomized, Double Blind, Placebo-controlled, Unicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of a Multi-funtion Toe Nail Patch in Patients Affected by Nail Fragility, Nail Mychosis and Psoriasis","Inclusion Criteria:\n\n* aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator.\n\nExclusion Criteria:\n\n* Patients that have proximal subungual onychomycosis, if their distal subungual onychomycosis is extended into the proximal portion of the nail or if it affects \\>75% of the nail.\n* Patients with conditions known to cause abnormal nail appearance, immunosuppression and signs of severe peripheral circulatory insufficiency\n* Patients who had used topical antifungal, anti-psoriasis nail treatment within one month or systemic antifungal treatment within three months.\n* Patients who have participated in another clinical nail study during the previous three months\n* Patients who have a known allergy to any of the study treatments.\n* Patients with unrelated nail disorders: onychomycosis, nail psoriasis, genetically induced onychodystrophy.\n* Patients with other nail disorders, active or severe psoriasis elsewhere, other autoimmune or inflammatory diseases.","ALL","18 Years",{"count":19,"type":20},72,"ESTIMATED","INTERVENTIONAL",[23],"PHASE3","A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up",[26,27,28],"Nail Psoriasis","Nail Damage","Mycosis",[30,31,32,33],"ONICOMYCOSIS","PATCH","UREA","PSORIASIS","RECRUITING","2026-01-22",{"date":37,"type":38},"2026-01-26","ACTUAL",{"date":40,"type":20},"2026-02",{"date":42,"type":20},"2026-12",{"name":44,"class":45},"Wooshin Labottach Co., Ltd.","INDUSTRY"]